ArticleACS pharmacology & translational science2025

Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors.

Sara El-Sahli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.